Corrigendum to “Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests” [J Microbiol Immunol Infect (2015) 924–933](S1684118215008191)(10.1016/j.jmii.2015.06.009)

研究成果: 雜誌貢獻評論/辯論同行評審

指紋

深入研究「Corrigendum to “Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests” [J Microbiol Immunol Infect (2015) 924–933](S1684118215008191)(10.1016/j.jmii.2015.06.009)」主題。共同形成了獨特的指紋。

Medicine & Life Sciences